Literature DB >> 8483517

Concentrations of albendazole in serum, cerebrospinal fluid and hydatidous brain cyst.

D Moskopp1, E Lotterer.   

Abstract

A young girl with cerebral echinococcosis was treated with albendazole (13 mg/kg/d, p.o.). The concentrations of albendazole sulphoxide were determined in serum, cerebrospinal fluid and hydatidous cyst over a month. The mean ratios of concentration were: CSF/serum = 50%, cyst/serum = 40%, cyst/CSF = 80%.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8483517     DOI： 10.1007/bf00308610

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   3.042


  11 in total

1.  Dexamethasone increases plasma levels of albendazole.

Authors:  H Jung; M Hurtado; M T Medina; M Sanchez; J Sotelo
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

2.  Sensitive high-performance liquid chromatographic assay for albendazole and its main metabolite albendazole sulphoxide in plasma and cerebrospinal fluid.

Authors:  M Hurtado; M T Medina; J Sotelo; H Jung
Journal:  J Chromatogr       Date:  1989-09-29

3.  Neurocysticercosis: treatment with albendazole and dextrochloropheniramine (preliminary report).

Authors:  S Agapejev; D A Meira; B Barraviera; J M Machado; P C Pereira; R P Mendes; A Kamegasawa; P R Curi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1988 Sep-Oct       Impact factor: 1.846

4.  Neurocysticercosis: treatment with albendazole.

Authors:  J Horton
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jan-Feb       Impact factor: 2.184

5.  Praziquantel vs. albendazol for cysticercosis.

Authors:  E Quintero-Rodriguez
Journal:  Neurosurgery       Date:  1988-07       Impact factor: 4.654

6.  Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.

Authors:  H Jung; M Hurtado; M Sanchez; M T Medina; J Sotelo
Journal:  Clin Neuropharmacol       Date:  1990-12       Impact factor: 1.592

7.  Short course of albendazole therapy for neurocysticercosis.

Authors:  J Sotelo; P Penagos; F Escobedo; O H Del Brutto
Journal:  Arch Neurol       Date:  1988-10

8.  Albendazole treatment of human cystic echinococcosis.

Authors:  T Todorov; K Vutova; D Petkov; G Mechkov; K Kolev
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

9.  [Echinococcosis. A case of echinococcosis multiocularis cerebri treated with mebendazole].

Authors:  C F Lindboe; J A Wilson; P E Hesla
Journal:  Tidsskr Nor Laegeforen       Date:  1983-01-10

10.  Albendazole therapy for neurocysticercosis.

Authors:  F Escobedo; P Penagos; J Rodriguez; J Sotelo
Journal:  Arch Intern Med       Date:  1987-04
View more
  7 in total

1.  Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.

Authors:  K W Henry; M C Cruz; S K Katiyar; T D Edlind
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London.

Authors:  H M Ayles; E L Corbett; I Taylor; A G A Cowie; J Bligh; K Walmsley; A D M Bryceson
Journal:  Ann R Coll Surg Engl       Date:  2002-03       Impact factor: 1.891

Review 3.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 4.  Multiple hydatid cysts of the brain: a case report and review of the literature.

Authors:  N Yüceer; M B Güven; H Yilmaz
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

5.  [Chemotherapy of alveolar echinococcosis with benzimidazoles. A prospective long-term study].

Authors:  S Reuter; W Kratzer; S Kurz; N Wellinghausen; P Kern
Journal:  Med Klin (Munich)       Date:  1998-08-15

6.  Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.

Authors:  Felix Lötsch; Judith Naderer; Tomislava Skuhala; Mirjam Groger; Herbert Auer; Klaus Kaczirek; Fredrik Waneck; Michael Ramharter
Journal:  Parasitol Res       Date:  2016-04-16       Impact factor: 2.289

Review 7.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.